Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout the day a recurring theme emerged: machine learning improves the affordability, speed, quality and utility of complex applications. Technology advancements over the last 5 years have …
Traditional NAFLD Activity Scoring Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of liver dysfunction, with some estimates suggesting up to 30% of the general population as being affected (1). NAFLD, while mainly asymptomatic, can progress to non-alcoholic steatohepatitis (NASH) in a portion of individuals. NASH is characterized by multiple pathologic …
imageDx: NASH – A New Generation of Quantitative NASH Data Read More »
What Are Spheroids? A spheroid is a small, spherical cluster of cells that acts as a 3D cell culture. The term “organoid” is also used interchangeably with “spheroid”, although the former specifically refers to a 3D cluster of organ-specific cells. Spheroids and organoids can be artificially assembled through different methods, including the use of centrifugal …
The rise of whole slide imaging has enabled a variety of computational tools to facilitate the extraction of quantitative data from tissue samples on microscope slides. The practice of using computational algorithms to collect these data from whole slide images is known as “image analysis”. Image analysis has already had an impact in drug development, …
The 110th Annual Meeting of the American Association for Cancer Research launched on March 30th, 2019 in Atlanta, GA. Over 22,000 delegates attended including scientists, clinicians, and patient advocates from around the globe. A team from Reveal Biosciences was present to highlight our recent advances in the application of artificial intelligence (AI) in pathology for …
San Diego, CA. (April 2nd, 2019). Reveal Biosciences, Inc., a leader in pathology AI, announces today that it has closed a Series A financing round led by Intel Capital with additional investment from the GNI Group and PP Capital. Reveal is focused on improving global healthcare by creating a new generation of objective, data-powered pathology …
The Digital Pathology Association recently released a white paper that provides a comprehensive overview of whole slide imaging, including the challenges and advantages of implementing this technology into existing workflows. You can read the full document here, but we’ve assembled the essential details in this article as a crash course on whole slide imaging. What …
Reveal Biosciences attended Biocom’s recent CRO seminar on Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice. Pharmatest Services and Taconic Biosciences hosted this informative seminar where they presented on humanized immune system models for immunotherapies and on humanized mouse models of bone metastasis. Paul Volden, Associate Director of External Collaboration and Innovation at Taconic …
Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice Read More »
Reveal Biosciences Founder and CEO, Dr. Claire Weston, was recently featured in the Tech Spotlight interview series. This interview covered topics such as the inception of Reveal Biosciences, the future impact of AI on pathology, and more. You can read the full interview on the Managed Solution website by clicking here. Here’s Claire’s response to …
Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston Read More »
Casey Laris, CTO of Reveal Biosciences, lead a webinar entitled “Revolutionize Pathology using Artificial Intelligence” as part of the Science Exchange Webinar Series. Highlights from this webinar include: Reveal Biosciences specializes in data powered pathology. The company offers a range of histopathology, immunohistochemistry (IHC), in situ hybridization (ISH), whole slide imaging and advanced image analysis …
Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence Read More »
Reveal Biosciences is improving global healthcare with a new generation of data powered pathology to characterize and detect disease.
Follow Us
contact
Reveal Biosciences, Inc.
6760 Top Gun St, Suite 110
San Diego, CA 92121
Copyright © 2023 All rights reserved.
Sign up to receive updates on the latest AI-powered pathology breakthroughs, access digital pathology resources, and more.